ArticleArchives of toxicology2026
Electronic cigarette aerosols disrupt airway barrier function via MMP-dependent E-cadherin cleavage: findings from cell culture and murine models.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Electronic cigarette (e-cigarette) use continues to rise, yet the toxicological mechanisms by which inhaled aerosols impair airway epithelial integrity remain poorly defined. E-cadherin, a key adherens junction protein required for epithelial cohesion, can undergo proteolytic cleavage to generate soluble E-cadherin (sE-cad), a mediator of epithelial barrier dysfunction and inflammation. We hypothesized that e-cigarette aerosol exposure promotes MMP-dependent E-cadherin cleavage, resulting in sE-cad release and epithelial barrier disruption. Using differentiated primary normal human bronchial epithelial (NHBE) cells, 16HBE cells, and a murine whole-body exposure model, we examined epithelial injury induced by physiologically relevant aerosols generated with a programmable puffing system. Air Factory salt e-liquid was used at 18 mg/mL nicotine for in vitro studies and 36 mg/mL for in vivo exposures. Immunoblotting demonstrated increased sE-cad levels in apical supernatants and bronchoalveolar lavage fluid. Aerosol exposure upregulated MMP-2, MMP-9, and MMP-12 expression. E-cigarette aerosol exposure significantly reduced transepithelial electrical resistance, increased FITC-dextran permeability, and disrupted airway epithelial barrier structure, indicating impaired barrier integrity and function. These effects were attenuated by pretreatment with the MMP inhibitor fisetin, which preserved barrier function and junctional protein localization. Fisetin treatment significantly reduced e-cigarette-induced sE-cad release and was associated with a marked reduction in MMP-9 expression, whereas MMP-2 and MMP-12 levels were not altered, identifying MMP-9 as a key mediator of E-cadherin cleavage. Collectively, these findings establish MMP-dependent E-cadherin cleavage as a mechanistic driver of e-cigarette-induced epithelial barrier dysfunction and identify sE-cad as a potential early biomarker and therapeutic target for aerosol-induced airway injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.